أرسل هذا في رسالة قصيرة: Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

  ______    _____     ______    _____     ______  
 /_____//  |  ___||  /_   _//  |  ___||  /_____// 
 `____ `   | ||__    `-| |,-   | ||__    `____ `  
 /___//    | ||__      | ||    | ||__    /___//   
 `__ `     |_____||    |_||    |_____||  `__ `    
 /_//      `-----`     `-`'    `-----`   /_//     
 `-`                                     `-`